Elevance Health stock holds firm after latest earnings estimates

Published on 09/17/2026 at 15:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Elevance Health stock traded at USD 418.78 on September 17, 2026, up 0.30 percent intraday. Analysts now see Sep 2026 EPS at USD 4.66 and revenue at USD 49.12 billion.

Modernes Krankenhaus-Campus mit Glasfassade und Patienten im Eingangsbereich — Elevance Health Krankenversicherungs-Campus US2855211023 zeigt modernen Gebäudeeingang mit weitläufiger Grünanlage unter blauem Himmel, Illustration mit AI erstellt.

Elevance Health stock (ISIN US2855211023) traded at USD 418.78 on September 17, 2026, up 0.30 percent in intraday trade on NYSE. Yahoo Finance showed the previous close at USD 417.54 and a pre-market level of USD 414.00 after the September 16 close.

EPS outlook stays pressured

At Yahoo Finance, the current quarter estimate for September 2026 stands at USD 4.66 a share, while the revenue forecast is USD 49.12 billion. That compares with year-ago sales of USD 50.09 billion and year-ago EPS of USD 6.03, a drop of 1.93 percent in revenue and a much sharper earnings decline.

The same analysis page lists full-year 2026 EPS at USD 27.16 and full-year 2026 revenue at USD 196.24 billion. For investors, the gap between the current-quarter EPS outlook and the year-ago figure is the number that matters most.

Market watches valuation

The stock closed at USD 412.56 on September 16, 2026, after a daily loss of 1.19 percent. In the same Yahoo Finance snapshot, Elevance Health was trading in a session range that put the shares close to the recent high zone, with the intraday chart showing USD 418.78 in morning trade.

Yahoo Finance also lists 19 analysts on the September 2026 earnings estimate, with the low estimate at USD 4.55 and the high at USD 4.99. That spread is tight, which suggests the market is focused more on execution than on a large earnings revision cycle.